Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2005-02-15
2005-02-15
Kunz, Gary (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S455000, C424S450000, C514S547000, C514S941000, C514S946000
Reexamination Certificate
active
06855332
ABSTRACT:
The present invention relates to pharmaceutical compositions comprising polyoxyethylene glycol, fatty acid mono- and diglyceride ester as an absorption promoting agent and an absorption controlling agent together with a therapeutically, prophylactically and/or diagnostically active substance. The pharmaceutical compositions are especially suitable for mucosal administration such as intranasal administration.
REFERENCES:
patent: 4349540 (1982-09-01), D'Hinterland et al.
patent: 4567161 (1986-01-01), Posanski et al.
patent: 5019395 (1991-05-01), Mahjour et al.
patent: 5177091 (1993-01-01), Feige et al.
patent: 5190748 (1993-03-01), Bachynsky et al.
patent: 5314685 (1994-05-01), Tyle et al.
patent: 5645856 (1997-07-01), Lacy et al.
patent: 5646109 (1997-07-01), Owen et al.
patent: 5719122 (1998-02-01), Chiodini et al.
patent: 5942237 (1999-08-01), Gizurarson et al.
patent: 6008228 (1999-12-01), Bailey et al.
patent: 6013277 (2000-01-01), Curri
patent: 6096338 (2000-08-01), Lacy et al.
patent: 6190695 (2001-02-01), Hoshino et al.
patent: 6217902 (2001-04-01), Tanner et al.
patent: 6267985 (2001-07-01), Chen et al.
patent: 6294192 (2001-09-01), Patel et al.
patent: 6309663 (2001-10-01), Patel et al.
patent: 6326401 (2001-12-01), Chauveau et al.
patent: 6383471 (2002-05-01), Chen et al.
patent: 6384034 (2002-05-01), Simitchieva et al.
patent: 6410046 (2002-06-01), Lerner
patent: 6451339 (2002-09-01), Patel et al.
patent: 6458383 (2002-10-01), Chen et al.
patent: 6468559 (2002-10-01), Chen et al.
patent: 6476042 (2002-11-01), Harrison
patent: 6495596 (2002-12-01), Keller
patent: 6514503 (2003-02-01), Gizurarson et al.
patent: 20010024658 (2001-09-01), Chen et al.
patent: 20020012673 (2002-01-01), Schroder
patent: 20020025509 (2002-02-01), Cima et al.
patent: 20020032171 (2002-03-01), Chen et al.
patent: 20030077297 (2003-04-01), Chen et al.
patent: 20030104048 (2003-06-01), Patel et al.
patent: 20030219472 (2003-11-01), Pauletti et al.
patent: 20030220391 (2003-11-01), Borgardus et al.
patent: 20030232078 (2003-12-01), Dong et al.
patent: 20030235595 (2003-12-01), Chen et al.
patent: 20030236236 (2003-12-01), Chen et al.
patent: 0 544 612 (1993-06-01), None
patent: 0351651 (1993-09-01), None
patent: WO 9902186 (1999-01-01), None
patent: WO 03016350 (2003-02-01), None
GlaxoSmithKline, Imitrex® (sumatriptan succinate), Drug Facts and Comparisons, p. 855, 2000.*
Lippold, B.C. and Ohm, A.M., “Effects of Surfactants, Polymers and Gastric Juice on Contact Angle of Drugs,”Acta Pharm. Technol., 32(1):20-25 (1986).
Zakrzewski, Z., et al., “The Effects of Adjuvants on the Physical Properties and Active-Substance Release from Oral Suspensions,” Goldschmidt Informiert, 57:14-17 (1982).
Gizurarson Sveinbjorn
Hrafnkelsdottir Kolbrun
Ingimundardottir Ellen Ruth
Ingolfsson Oddur
Kristinsson Jakob Lindal
Haghighatian Mina
Hamilton Brook Smith & Reynolds P.C.
Kunz Gary
Lyfjathroun hf.
LandOfFree
Absorption promoting agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Absorption promoting agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Absorption promoting agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3468962